IDEXX CEO resigns following spinal cord injuryOctober 25, 2019Jonathan Ayers, president, CEO, and chair of IDEXX Laboratories, is stepping down after suffering a spinal cord injury.
Education Center - SponsoredRethinking Our Approach to Canine OA: Treating synovial inflammationby • Exubrion TherapeuticsIt’s time to reframe arthritis not just as a painful condition, but as a disease of rampant synovial inflammation. In adopting a proactive treatment strategy that is aimed at modulating the inflammatory process, veterinarians can now provide more effective, long-term care.
